Pathstone Family Office’s Trilogy Metals TMQ Stock Holding History

Pathstone Family Office’s Portfolio TMQ Stock Details TMQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,000	Closed	–	–	1365
2022 Q4	$0	Buy	+20,000	New	+$11.7K	﹤0.01%	1403

Other funds holding TMQ

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

GRA

Goehring & Rozencwajg Associates New York $1.74B AUM 48.6% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return

Sprott Inc Toronto, Ontario, Canada $3.15B AUM 70.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pathstone Family Office's TMQ Position: Q1 2023 in Review

Pathstone Family Office sold out of Trilogy Metals (TMQ) in Q1 2023, closing a stake of 20,000 shares.

Pathstone Family Office first reported a position in TMQ in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 46 funds tracked by Wall St. Rank hold TMQ as of Q1 2023.

Pathstone Family Office reported no remaining Trilogy Metals position as of Q1 2023 after selling out during the quarter.
Pathstone Family Office sold 20,000 Trilogy Metals shares in Q1 2023.
Pathstone Family Office first reported a position in Trilogy Metals in Q4 2022 and held it in 1 quarter.
Pathstone Family Office's Trilogy Metals position peaked at $0 in Q4 2022.
46 funds tracked by Wall St. Rank held Trilogy Metals as of Q1 2023.

Based on Pathstone Family Office's 13F filing for Q1 2023, filed 15 May 2023.